Works matching AU Adkins, Douglas
Results: 60
Cisplatin exposure causes c-Myc-dependent resistance to CDK4/6 inhibition in HPV-negative head and neck squamous cell carcinoma.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 11, p. 1, doi. 10.1038/s41419-019-2098-8
- By:
- Publication type:
- Article
Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41419-017-0029-0
- By:
- Publication type:
- Article
A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas.
- Published in:
- Cell Death & Disease, 2016, v. 7, n. 10, p. e2406, doi. 10.1038/cddis.2016.232
- By:
- Publication type:
- Article
Long-term outcomes of allogeneic stem cell transplant recipients after calcineurin inhibitor-induced neurotoxicity.
- Published in:
- British Journal of Haematology, 2003, v. 123, n. 1, p. 110, doi. 10.1046/j.1365-2141.2003.04550.x
- By:
- Publication type:
- Article
Dynamic host immune response in virus-associated cancers.
- Published in:
- Communications Biology, 2019, v. 2, n. 1, p. N.PAG, doi. 10.1038/s42003-019-0352-3
- By:
- Publication type:
- Article
Treatment Outcomes for T4 Oropharyngeal Squamous Cell Carcinoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma.
- Published in:
- Rare Tumors, 2021, p. 1, doi. 10.1177/20363613211052498
- By:
- Publication type:
- Article
Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma.
- Published in:
- Rare Tumors, 2021, p. 1, doi. 10.1177/20363613211052498
- By:
- Publication type:
- Article
Hearing Outcomes in a Deintensification Trial of Adjuvant Therapy for HPV‐Related Oropharyngeal Squamous Cell Carcinoma.
- Published in:
- Otolaryngology-Head & Neck Surgery, 2023, v. 168, n. 5, p. 1089, doi. 10.1002/ohn.182
- By:
- Publication type:
- Article
Induction chemotherapy in the treatment of nasopharyngeal carcinoma: Clinical outcomes and patterns of care.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 8, p. 3592, doi. 10.1002/cam4.1626
- By:
- Publication type:
- Article
Nab-paclitaxel-based compared to docetaxel-based induction chemotherapy regimens for locally advanced squamous cell carcinoma of the head and neck.
- Published in:
- Cancer Medicine, 2015, v. 4, n. 4, p. 481, doi. 10.1002/cam4.382
- By:
- Publication type:
- Article
A prospective trial comparing FDG- PET/ CT and CT to assess tumor response to cetuximab in patients with incurable squamous cell carcinoma of the head and neck.
- Published in:
- Cancer Medicine, 2014, v. 3, n. 6, p. 1493, doi. 10.1002/cam4.294
- By:
- Publication type:
- Article
Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapy.
- Published in:
- Cancer Medicine, 2014, v. 3, n. 3, p. 603, doi. 10.1002/cam4.209
- By:
- Publication type:
- Article
Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Transoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Transoral laser microsurgery (TLM) ± adjuvant therapy for advanced stage oropharyngeal cancer.
- Published in:
- Laryngoscope, 2009, v. 119, n. 9, p. 1709, doi. 10.1002/lary.20552
- By:
- Publication type:
- Article
Temporal Relationship Between Antitumor Necrosis Factor-α Antibody Therapy and Recrudescence of Head and Neck Squamous Cell Carcinoma.
- Published in:
- Laryngoscope, 2008, v. 118, n. 3, p. 450, doi. 10.1097/MLG.0b013e31815abf4c
- By:
- Publication type:
- Article
Cisplatin versus Cetuximab Given Concurrently with Definitive Radiation Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma.
- Published in:
- Oncology, 2013, v. 85, n. 5, p. 290, doi. 10.1159/000355194
- By:
- Publication type:
- Article
A Phase I Study of the Safety and Pharmacokinetics of the Hypoxia-Activated Prodrug TH-302 in Combination with Doxorubicin in Patients with Advanced Soft Tissue Sarcoma.
- Published in:
- Oncology, 2011, v. 80, n. 1/2, p. 50, doi. 10.1159/000327739
- By:
- Publication type:
- Article
Outcomes of Patients With Single-Node Metastasis of Human Papillomavirus-Related Oropharyngeal Cancer Treated With Transoral Surgery.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Risk and Rate of Occult Contralateral Nodal Disease in Surgically Treated Patients With Human Papillomavirus-Related Squamous Cell Carcinoma of the Base of the Tongue.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Association of Posttreatment Lymphopenia and Elevated Neutrophil-to-Lymphocyte Ratio With Poor Clinical Outcomes in Patients With Human Papillomavirus-Negative Oropharyngeal Cancers.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Comparison of unilateral versus bilateral intensity-modulated radiotherapy for surgically treated squamous cell carcinoma of the palatine tonsil.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 24, p. 3994, doi. 10.1002/cncr.28938
- By:
- Publication type:
- Article
A phase 2 trial of induction nab-paclitaxel and cetuximab given with cisplatin and 5-fluorouracil followed by concurrent cisplatin and radiation for locally advanced squamous cell carcinoma of the head and neck.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 4, p. 766, doi. 10.1002/cncr.27741
- By:
- Publication type:
- Article
Head and neck carcinoma in the United States.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 23, p. 5783, doi. 10.1002/cncr.27609
- By:
- Publication type:
- Article
A phase 2 study of temsirolimus (CCI-779) in patients with soft tissue sarcomas: a study of the Mayo phase 2 consortium (P2C).
- Published in:
- 2011
- By:
- Publication type:
- journal article
A phase 2 study of temsirolimus (CCI-779) in patients with soft tissue sarcomas.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 15, p. 3468, doi. 10.1002/cncr.25928
- By:
- Publication type:
- Article
Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a randomized, double-blind safety study comparing cetuximab produced from two manufacturing processes using the EXTREME study regimen.
- Published in:
- 2016
- By:
- Publication type:
- journal article
T cell subtype profiling measures exhaustion and predicts anti-PD-1 response.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-05474-7
- By:
- Publication type:
- Article
Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study.
- Published in:
- Thyroid, 2024, v. 34, n. 1, p. 26, doi. 10.1089/thy.2023.0363
- By:
- Publication type:
- Article
An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer.
- Published in:
- Thyroid, 2020, v. 30, n. 9, p. 1254, doi. 10.1089/thy.2019.0269
- By:
- Publication type:
- Article
Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37266-6
- By:
- Publication type:
- Article
Outcomes of relapsed human papillomavirus‐related oropharyngeal squamous cell carcinoma treated with curative intent.
- Published in:
- Head & Neck, 2019, v. 41, n. 5, p. 1312, doi. 10.1002/hed.25557
- By:
- Publication type:
- Article
Patterns of care and survival outcomes for laryngeal small cell cancer.
- Published in:
- Head & Neck, 2019, v. 41, n. 3, p. 722, doi. 10.1002/hed.25430
- By:
- Publication type:
- Article
Pretreatment metabolic tumor volume as a prognostic factor in HPV‐associated oropharyngeal cancer in the context of AJCC 8th edition staging.
- Published in:
- Head & Neck, 2018, v. 40, n. 10, p. 2280, doi. 10.1002/hed.25337
- By:
- Publication type:
- Article
Reevaluation of postoperative radiation dose in the management of human papillomavirus-positive oropharyngeal cancer.
- Published in:
- Head & Neck, 2016, v. 38, n. 11, p. 1643, doi. 10.1002/hed.24486
- By:
- Publication type:
- Article
PRISM: Phase 2 trial with panitumumab monotherapy as second-line treatment in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
- Published in:
- Head & Neck, 2016, v. 38, p. E1756, doi. 10.1002/hed.24311
- By:
- Publication type:
- Article
Squamous cell cancer of the head and neck with distant metastasis at presentation.
- Published in:
- Head & Neck, 2011, v. 33, n. 5, p. 714, doi. 10.1002/hed.21529
- By:
- Publication type:
- Article
First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 5, p. 990, doi. 10.1007/s10637-022-01274-y
- By:
- Publication type:
- Article
Alliance A091103 a phase II study of the angiopoietin 1 and 2 peptibody trebananib for the treatment of angiosarcoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 3, p. 629, doi. 10.1007/s00280-015-2689-8
- By:
- Publication type:
- Article
A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1225, doi. 10.1007/s00280-010-1410-1
- By:
- Publication type:
- Article
Tazemetostat, a Selective EZH2 Inhibitor, in Combination with Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 1 Trial.
- Published in:
- Cancers, 2025, v. 17, n. 3, p. 437, doi. 10.3390/cancers17030437
- By:
- Publication type:
- Article
Immune Cell Deconvolution Reveals Possible Association of γδ T Cells with Poor Survival in Head and Neck Squamous Cell Carcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4855, doi. 10.3390/cancers15194855
- By:
- Publication type:
- Article
Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2355, doi. 10.3390/cancers14102355
- By:
- Publication type:
- Article
nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a multicenter, non-randomized phase 2 trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
nab-Paclitaxel-based induction chemotherapy followed by cisplatin and radiation therapy for human papillomavirus-unrelated head and neck squamous-cell carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prospective assessment of the clinical benefit of a tailored cancer gene set built on a next-generation sequencing platform in patients with recurrent or metastatic head and neck cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article